Abstract
Transport ATPases can be lumped into four distinct types, P, F, V, and ABC, with the first three designated 20 years ago (Pedersen, P.L. and Carafoli, E., Trends Biochem. Sci. 12, 146–150, 1987) and the ABC type included more recently. The mini-reviews (>20) that comprise this volume of the Journal of Bioenergetics and Biomembranes describe work presented at the 2007 FASEB Conference (6th) on Transport ATPases (Kathleen Sweadner, Chair; Rajini Rao, Co-Chair). Since these conferences began in 1997, the “transport ATPase field” has seen tremendous progress. Advances include a much better understanding of the structure, mechanism, and regulation of each of the four major ATPase types as well as their physiological and medical relevance. In fact, the transport ATPase field has entered a new era in which work on these enzymes is likely to contribute to new therapies for multiple diseases that affect both people and animals. Among these are cancer and heart disease, mitochondrial diseases, osteoporosis, macromolecular degeneration, immune deficiency, cystic fibrosis, diabetes, ulcers, nephro-toxicity, hearing loss, skin disorders, lupus, and malaria. In addition, as several members of the transport ATPase family include those involved in drug resistance their study may help alleviate this recurring problem in drug development. Finally, the transport ATPase field is also paving the way for nanotechnology focused on nano-motors with work on the F-type ATPases (F0F1) leading the way. These ATPases driven in reverse by a proton gradient have the capacity to interconvert electrochemical energy into mechanical energy and finally into chemical energy conserved in the terminal bond of ATP. In mammalian mitochondria these events occur on a larger complex or “nano-machine” called the “ATP synthasome” that consists of the ATP synthase in complex formation with carriers for Pi and ADP/ATP.
References
Abrahams JP, Leslie AG, Lutter R, Walker JE (1994) Nature 370:621–628
Ambudkar SV, Kimchi-Sarfaty C, Sauna ZE, Gottesman MM (2003) Oncogene 22:7468–7485
Andersen JB, Vilsen B (1995) FEBS Lett 359:101–106
Bianchet MA, Hullihen J, Pedersen PL, Amzel LM (1998) Proc Natl Acad Sci U S A 95:11065–11070
Blum DJ, Ko YH, Hong S, Rini DA, Pedersen PL (2001) Biochem Biophys Res Commun 287:801–807
Cain BD (2000) J Bioenerg Biomemb 32:365–371
Caplan MJ (2007) J Clin Gastroenterol 41:S217–222
Charnock JS, Rosenthal AS, Post RL (1963) Aust J Exp Biol Med 41:675–686
Chen C, Ko Y, Delannoy M, Ludtke SJ, Chiu W, Pedersen PL (2004) J Biol Chem 279:31761–31768
Chen C, Saxena AK, Simcoke WN, Garboczi DN, Pedersen PL, Ko YH (2006) J Biol Chem 281:13777–13783
Davidson AI, Chen J (2004) Annu Rev Biochem 73:241–268
Dean M, Annilo T (2005) Annu Rev Genomics Hum Genet 6:123–142
Dean M, Rzhetsky A, Allikmets R (2001) Genome Res 11:1156–1166
Dickson VK, Silvester JA, Fearnley IM, Leslie AG, Walker JE (2006) EMBO J 25:2911–2918
Dmitriev O, Tsivkovskii R, Abildgaard F, Morgan CT, Markley JL, Lutsenko S (2006) Proc Natl Acad Sci U S A 103:5302–5307
Drory O, Nelson N (2006) Physiology (Bethesda) 21:317–325
Einholm AP, Andersen JP, Vilsen B (2007) J Bioenerg Biomembranes 39 (5/6) (this volume)
Gerle C, Tani K, Yokoyama K, Tamakoshi M, Yoshida M, Fujiyyoshi Y, Mitsuoka K (2006) J Struct Biol 153:200–206
Golden TR, Pedersen PL (1998) Biochemistry 37:13871–13881
Gottesman MM, Ambudkar S (2001) J Bioenerg Biomemb 33:453–458
Hatori Y, Majima E, Tsuda T, Toyoshima C (2007) J Biol Chem 282:25213–25221
Higgins CF (2001) Res Microbiol 152:205–210
Hollenstein K, Dawson RJP, Locher KP (2007) Curr Opin Struct Biol 17:412–418
Imamura H, Takeda M, Funamoto S, Shimabukuro K, Yoshida M, Yokoyama K (2005) Proc Natl Acad Sci U S A 102:17929–33
Kenan DJ, Wahl ML (2005) J Bioenerg Biomembranes 37:461–465
Ko YH, Bianchet M, Amzel LM, Pedersen PL (1997) J Biol Chem 272:18875–18881
Ko YH, Delannoy M, Hullihen J, Chiu W, Pedersen PL (2003) J Biol Chem 278:12305–12309
Ko YH, Hong S, Pedersen PL (1999) J Biol Chem 274:28853–28856
Ko YH, Hullihen J, Hong S, Pedersen PL (2000) J Biol Chem 275:32931–32939
Lou H, Dean M (2007) Oncogene 26:1357–1360
Morth JP, Pedersen BP, Toustrup-Jensen MS, Sorensen TL-M, Petersen J, Andersen JP, Vilsen B, Nissen P (2007) Nature 450:1043–1049
Moody JE, Thomas PJ (2005) J Bioenerg Biomemb 37:475–479
Moser TL, Stack MS, Asplin I, Enghild JJ, Hojrup P, Everitt L, Hubchak S, Schnaper HW, Pizzo SV (1999) Proc Natl Acad Sci U S A 96:2811–2816
Noji H, Yamada R, Yoshida M, Kinsosita K Jr (1997) Nature 386:299–302
Omote H, Sambonmatsu N, Saito K, Sambongi Y, Iwamoto-Kihara A, Yanagida T, Wada Y, Futai M (1999) Proc Natl Acad Sci U S A 96:7780–7784
Pedersen PL (2002) J Bioenerg Biomembranes 34:327–332
Pedersen PL (2005) J Bioenerg Biomembranes 37:349–357
Pedersen PL, Carafoli E (1987) Trends Biochem Sci 12:186–189
Post RL, Sen AK, Rosenthal AS (1965) J Biol Chem 240:1437–1445
Skou JC (1957) Biochem Biophys Acta 23:394–401
Stock D, Gibbons C, Arechaga I, Leslie AG, Walker JE (2000) Curr Opin Struct Biol 10:672–679
Toyoshima C (2007) Adv Exp Med Biol 592:295–303
Toyoshima C, Inesi G (2004) Annu Rev Biochem 73:269–292
Vik SB, Antonio BJ (1994) J Biol Chem 269:30364–30369
Wilkens S, Capaldi RA (1998) Nature 393:329
Wilkens S, Inoue T, Forgac M (2004) J Biol Chem 279:41942–41949
Wilkens S, Zhang Z, Zheng Y (2005) Micron 36:109–126
Xu J, Cheng T, Feng HT, Pavlos NJ, Zheng MH (2007) Histol Histopathol 22:443–454
Acknowledgements
The author is grateful for support from NIH via research grants CA 10951 and CA 80018, to Dr. Young Ko for helpful discussions, and to David Blum and Young Ko for their expert help in preparing the figures.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pedersen, P.L. Transport ATPases into the year 2008: a brief overview related to types, structures, functions and roles in health and disease. J Bioenerg Biomembr 39, 349–355 (2007). https://doi.org/10.1007/s10863-007-9123-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10863-007-9123-9